Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F L Hu

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Zhonghua Yi Xue Za Zhi|May 11, 2022
[A multi-center, randomized controlled study on the effect of <i>Saccharomyces boulardii</i> combined with triple therapy for the initial eradication of <i>Helicobacter pylori</i> infection]G B Yang, F L Hu, W Cheng, et al.
Zhonghua Yi Xue Za Zhi|November 18, 2016
[Jinghuaweikang capsules combined with furazolidone-based triple or quadruple therapy as the rescue treatment for Helicobacter pylori infection: a multicenter randomized controlled clinical trial]H Cheng, F L Hu, J Q Sheng, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 19, 2022
[A cross-sectional study on the clinical phenotypes of rheumatoid arthritis]W X Cai, S C Li, Y M Liu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 26, 2020
[A prospective cohort study on blood pressure control and risk of ischemic stroke in patients with hypertension]C Y Wang, L M Cao, J Shi, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2000
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled studyB C Wong, S D Xiao, F L Hu, et al.
Zhonghua Yi Xue Za Zhi|January 29, 2026
[Analysis of the efficacy and safety of magaldrate granules quadruple therapy in the treatment of <i>Helicobacter pylori</i> infection]X H Dong, J X Liu, W Gao, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Zhonghua Yi Xue Za Zhi|May 11, 2022
[A multi-center, randomized controlled study on the effect of <i>Saccharomyces boulardii</i> combined with triple therapy for the initial eradication of <i>Helicobacter pylori</i> infection]G B Yang, F L Hu, W Cheng, et al.
Zhonghua Yi Xue Za Zhi|November 18, 2016
[Jinghuaweikang capsules combined with furazolidone-based triple or quadruple therapy as the rescue treatment for Helicobacter pylori infection: a multicenter randomized controlled clinical trial]H Cheng, F L Hu, J Q Sheng, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|December 19, 2022
[A cross-sectional study on the clinical phenotypes of rheumatoid arthritis]W X Cai, S C Li, Y M Liu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 26, 2020
[A prospective cohort study on blood pressure control and risk of ischemic stroke in patients with hypertension]C Y Wang, L M Cao, J Shi, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2001
Three-day lansoprazole quadruple therapy for Helicobacter pylori-positive duodenal ulcers: a randomized controlled studyB C Wong, W H Wang, W M Wong, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2000
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled studyB C Wong, S D Xiao, F L Hu, et al.
Zhonghua Yi Xue Za Zhi|January 29, 2026
[Analysis of the efficacy and safety of magaldrate granules quadruple therapy in the treatment of <i>Helicobacter pylori</i> infection]X H Dong, J X Liu, W Gao, et al.
Pageof 4